CELADON PHARMACEUTICALS PLC
Vertically integrated pharma developing cannabis medicines for chronic pain.
CEL | IL
Overview
Corporate Details
- ISIN(s):
- GB00BDQYGP38
- LEI:
- 213800YXCATORT475807
- Country:
- United Kingdom
- Address:
- 32-33 COWCROSS STREET, EC1M 6DF LONDON
- Website:
- https://celadonpharma.co.uk/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Celadon Pharmaceuticals PLC is a vertically integrated pharmaceutical company focused on the research, cultivation, manufacturing, and commercial sale of cannabis-based medicines. The company's primary target market is chronic pain, aiming to provide alternatives to traditional treatments. It operates a licensed, 100,000 sq ft, EU-GMP certified facility for the indoor cultivation of high-THC cannabis and the extraction of Active Pharmaceutical Ingredients (API). A key differentiator is its MHRA-conditionally approved clinical trial for chronic pain, which seeks to generate robust data for potential reimbursement by national health services. Founded in 2018, Celadon is also engaged in R&D to generate novel intellectual property and develop a pipeline of prescription medicines for various conditions.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CELADON PHARMACEUTICALS PLC and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-28 17:10 |
Post-Annual General Meeting Information
Result of General Meeting
|
English | 20.4 KB | |
| 2025-07-02 08:00 |
Pre-Annual General Meeting Information
Proposed Cancellation
|
English | 99.3 KB | |
| 2025-07-01 12:48 |
Capital/Financing Update
Funding Update
|
English | 10.8 KB | |
| 2025-07-01 09:20 |
Post-Annual General Meeting Information
Result of AGM
|
English | 24.0 KB | |
| 2025-06-30 08:00 |
Report Publication Announcement
Funding and Operational Update, Delay in Results
|
English | 22.5 KB | |
| 2025-06-11 08:00 |
Capital/Financing Update
New Committed Credit Facility
|
English | 14.2 KB | |
| 2025-06-06 16:55 |
Regulatory News Service
Funding Update, Notice of AGM
|
English | 12.1 KB | |
| 2025-05-30 19:07 |
Capital/Financing Update
Funding Update
|
English | 11.3 KB | |
| 2025-03-19 08:00 |
Capital/Financing Update
Funding Update
|
English | 11.8 KB | |
| 2025-02-26 14:00 |
Capital/Financing Update
New Committed Credit Facility
|
English | 15.5 KB | |
| 2025-02-12 08:00 |
Capital/Financing Update
Finance Update
|
English | 10.4 KB | |
| 2025-01-31 08:00 |
Capital/Financing Update
Finance Update
|
English | 10.7 KB | |
| 2025-01-16 08:00 |
Regulatory News Service
Update on Strategic Collaboration
|
English | 13.7 KB | |
| 2025-01-02 08:00 |
Capital/Financing Update
Funding Update
|
English | 10.6 KB | |
| 2024-12-20 08:00 |
Capital/Financing Update
Finance Update
|
English | 10.8 KB |
Automate Your Workflow. Get a real-time feed of all CELADON PHARMACEUTICALS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for CELADON PHARMACEUTICALS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
